Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 27, 2009

Diagnosis of infection with human herpes viruses in routine laboratory practice

  • Nazanin Mostafaie , Klaus R. Huber , Christian Sebesta , Kurt Bauer , Wolfgang Kristoferitsch , Beatrix Volc-Platzer , Herbert Kurz , Ilse Klinghofer , Borka Mirkovic , Jörg Hofmann , Milos Hejtman , Karl Schrattbauer and Walter Krugluger

Abstract

Background: The potential for faster detection of human herpes viruses using PCR compared to other methods is undisputed. However, because of fear of contamination, the clinical implication of nucleic amplification methods in routine laboratories is not widespread. Herpes viruses cause a wide spectrum of diseases and can cause morbidity and mortality in immune-compromised patients. Using real-time PCR, most of the problems associated with PCR (contamination, cumbersome detection, and rather expensive tests) are solved, and a rapid, economical, and – most importantly – closed system is at hand.

Methods: We evaluated work procedures in our laboratory that enable the routine diagnosis of viral infections with high accuracy and rapid turn-around time. In parallel, inherent problems usually associated with PCR testing, especially cross-contamination could be suppressed to a minimum. The start of the work flow process begins with an automated nucleic acid extraction procedure that yields high quality DNA. A common – internally and externally controlled – PCR program for all six viruses allows rapid sample turn around.

Results: In all, 7500 analyses for human herpes virus infection were performed in the last 5 years. Results for various different specimens were produced within 24 h. Contamination occurred rarely and could be ameliorated easily. The use of internal controls identified rare PCR-inhibited samples. The detection limits for our assays are markedly below the clinically relevant range.

Conclusions: Our workflow allowed rapid, cost-efficient, and labor saving routine diagnostic detection of viral infections.

Clin Chem Lab Med 2009;47:1141–5.


Corresponding author: Klaus R. Huber, Prof. PhD, Department of Clinical Chemistry, Donauspital, Langobardenstrasse 122, 1220 Vienna, Austria Phone: +43 1-28802-5024, Fax: +43 1-28802-5080,

Received: 2009-4-6
Accepted: 2009-6-19
Published Online: 2009-07-27
Published in Print: 2009-09-01

©2009 by Walter de Gruyter Berlin New York

Downloaded on 29.3.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2009.251/html
Scroll to top button